New York Southern District Court
Judge:Alison J Nathan
Case #: 1:19-cv-01654
Nature of Suit850 Other Statutes - Securities/Commodities/Exchange
Cause15:78j(b)ss Stockholder Suit
Case Filed:Feb 21, 2019
Terminated:Oct 14, 2020
Last checked: Tuesday Aug 20, 2019 4:32 AM EDT
Defendant
Boyu Capital Fund II, L.P.
Represented By
Gideon Alexander Schor
Wilson Sonsini Goodrich & Rosati (nyc)
contact info
Boris Feldman
Wilson, Sonsini, Goodrich & Rosati
contact info
Ignacio E. Salceda
Wilson Sonsini Goodrich & Rosati (ca)
contact info
Defendant
Ning Zhao
Defendant
Zhaohui Zhang
Defendant
Yunfeng II WX Limited
Defendant
Yinfu Capital Management Co.
Defendant
WuXi PharmaTech (Cayman) Inc.
Represented By
Gideon Alexander Schor
Wilson Sonsini Goodrich & Rosati (nyc)
contact info
Boris Feldman
Wilson, Sonsini, Goodrich & Rosati
contact info
Ignacio E. Salceda
Wilson Sonsini Goodrich & Rosati (ca)
contact info
Defendant
Temasek Life Sciences Private Limited
Represented By
Roger Allen Cooper
Cleary Gottlieb
contact info
Defendant
Sequoia Capital China Growth Fund III, L.P.
Defendant
SPDB International Holdings Limited
Defendant
Ping An Life Insurance Company of China. Ltd.
Defendant
Xiaozhong Liu
Defendant
Ge Li
Defendant
Edward Hu
Defendant
Hillhouse Capital Fund II, L.P.
Defendant
G&C Partnership L.P.
Defendant
G&C IV Limited
Defendant
Constant Cypress Limited
Defendant
ABG II-WX Limited
Lead Plaintiff
Altimeo Asset Management
Represented By
Jeremy Alan Lieberman
Pomerantz LLP
contact info
Michael Grunfeld
Pomerantz LLP
contact info
Joseph Alexander Hood, II
Pomerantz LLP
contact info
TERMINATED PARTIES
Defendant
WuXi Merger Limited
Terminated: 07/30/2019
Defendant
New WuXi Life Science Limited
Terminated: 07/30/2019
Defendant
New WuXi Life Science Holdings Limited
Terminated: 07/30/2019


Docket last updated: 11/22/2024 11:59 PM EST
Wednesday, October 28, 2020
76 76 notice Notice (Other) Wed 10/28 5:12 PM
NOTICE of STIPULATION CONCERNING DISSMISAL OF ACTION. Document filed by Altimeo Asset Management..(Grunfeld, Michael)
Related: [-]